Declaring monetary value and units sold under Canada's Access to Medicines Regime (English, HTML)

View metadata and access the original English HTML file: Declaring monetary value and units sold under Canada's Access to Medicines Regime.

Format

HTML

Access

file-only

Publisher-reported update

2020-09-17

Within 15 days of the day on which the compulsory licence was granted or the supply agreement was signed, whichever is later, the pharmaceutical company must complete and submit to the patent holder and the Commissioner of Patents a "Solemn or Statutory Declaration Under Paragraph 21.16(1)(b) of the Patent Act".

Access original file